What Is Insulin Resistance? Symptoms, Causes, Testing, and Treatment Options

Insulin resistance means your muscle, fat, and liver cells do not respond to insulin as well as they should. Your pancreas may make more insulin to keep blood sugar normal at first, but over time blood sugar can rise, increasing the risk of prediabetes, type 2 diabetes, fatty liver disease, and heart problems 1.

What does insulin resistance mean in simple terms?

Insulin resistance means your cells are less responsive to insulin, the hormone that helps move glucose from your blood into cells for energy. In the early stage, the pancreas may compensate by making extra insulin, a state called hyperinsulinemia 1.

What insulin does after you eat

After a meal, carbohydrates are broken down into glucose. Insulin acts like a signal that tells muscle, fat, and liver cells to take up or store that glucose, helping blood glucose return toward its usual range 1.

What changes when cells stop responding well to insulin

When insulin sensitivity drops, the same insulin signal does not work as well. The pancreas may respond by making more insulin, but if that compensation fails over time, blood glucose can rise into the prediabetes or type 2 diabetes range 1, 2.

Why blood sugar can be normal at first

A normal fasting glucose or A1C does not always mean insulin signaling is perfect. Some people keep normal blood glucose for years because their pancreas is working harder than usual, which is why symptoms alone are not a reliable way to know what is happening 1.

Quick facts about insulin resistance

Insulin resistance is common, often quiet, and best understood as a metabolic pattern rather than a single diagnosis. The most useful first step is usually risk-based screening with a licensed clinician, not guessing from symptoms.

• Definition: reduced response of muscle, fat, and liver cells to insulin 1.
• Symptoms: often none; some people notice signs related to high blood sugar, such as thirst, frequent urination, fatigue, or blurred vision 1.
• Testing: routine care usually screens for prediabetes and diabetes with A1C, fasting plasma glucose, or an oral glucose tolerance test, rather than directly measuring insulin resistance 1.
• First steps: exercise, weight loss when appropriate, and evidence-based eating patterns can improve insulin resistance markers 6, 7.

What are the symptoms of insulin resistance?

Insulin resistance often has no clear symptoms. That is why a person can feel fine for years while metabolic risk slowly changes 1.

When blood glucose is high, possible symptoms include increased thirst, frequent urination, fatigue, blurred vision, or slow-healing cuts. These symptoms are not specific to insulin resistance, so they should prompt medical evaluation rather than self-diagnosis 1.

Other clues can include a larger waist size, skin tags, dark velvety skin in body folds, PCOS-related cycle changes, elevated triglycerides, fatty liver disease, or high blood pressure. These clues do not prove insulin resistance, but they are worth discussing with a clinician, especially if you also have family history or weight-related risk 1, 3.

What causes insulin resistance?

Insulin resistance usually has more than one cause. Genetics, visceral fat, low muscle activity, hormones, sleep, liver metabolism, and some medicines can all affect insulin sensitivity over time 1, 3.

• Body weight and waist size: excess visceral adiposity, or fat around abdominal organs, is strongly linked with insulin resistance and metabolic syndrome 1, 3.
• Physical inactivity: skeletal muscle is a major site for glucose use, and inactivity can reduce muscle insulin sensitivity 3, 6.
• Family history, age, and pregnancy history: risk is higher with family history of type 2 diabetes, age 35 or older, and a history of gestational diabetes 1.
• PCOS: polycystic ovary syndrome is often linked with insulin resistance, and trials in PCOS have studied diet patterns and insulin-sensitizing approaches 7, 8.
• Other conditions: sleep apnea, nonalcoholic fatty liver disease, metabolic dysfunction-associated steatotic liver disease, Cushing’s syndrome, and acromegaly can be associated with insulin resistance 1, 10.
• Medicines: glucocorticoids and some antipsychotic medicines can worsen insulin resistance in some people 1, 4.

Is insulin resistance the same as prediabetes or diabetes?

Insulin resistance is not the same as prediabetes or type 2 diabetes. It can come before blood glucose rises high enough to meet prediabetes or diabetes criteria 1.

Prediabetes means blood glucose is above normal but not high enough for type 2 diabetes. Type 2 diabetes means blood glucose is in the diabetes range and can affect the heart, eyes, kidneys, nerves, and blood vessels over time 1. For a deeper comparison, see our guide to insulin resistance and diabetes and diabetes versus insulin resistance.

How do clinicians test for insulin resistance?

Insulin resistance is hard to measure directly in routine care. Most clinicians screen for prediabetes and diabetes with blood glucose tests instead 1, 2.

Common tests include fasting plasma glucose, A1C, and the oral glucose tolerance test. These tests do not measure insulin sensitivity directly, but they show whether blood glucose is normal, in the prediabetes range, or in the diabetes range 1.

HOMA-IR uses fasting insulin and fasting glucose to estimate insulin resistance, but it is more common in research than in routine diagnosis. The hyperinsulinemic-euglycemic clamp is often called a reference method for measuring insulin sensitivity in research, but it is time-intensive and not a standard clinic screening test 2, 3.

How can insulin resistance improve?

Insulin sensitivity can improve when the plan fits the person. The strongest starting points are usually exercise, weight loss when clinically appropriate, and sustainable eating patterns, with progress tracked over months, not days 1, 6.

Exercise and strength training

Structured exercise can improve insulin resistance-related outcomes in people with type 2 diabetes. In a randomized controlled trial published in PLOS One in 2024, a structured exercise program improved insulin resistance and quality-of-life measures in adults with type 2 diabetes 6.

Weight loss when clinically appropriate

For people with overweight or obesity, losing weight can reduce metabolic stress and improve insulin sensitivity. The safest target and pace depend on health history, medications, pregnancy plans, eating-disorder history, and lab results 1. If your main question is prediabetes risk, our guide to weight loss for prediabetes explains the evidence in more detail.

Diet patterns with stronger evidence

No single food fixes insulin resistance. In women with PCOS, a randomized clinical trial found that a DASH-style diet improved insulin resistance markers and inflammation markers compared with a control diet 7. DASH-style eating usually emphasizes vegetables, fruits, beans, whole grains, nuts, low-fat dairy when tolerated, and lower sodium.

Sleep, smoking, and long-term risk

Sleep apnea, smoking, high blood pressure, abnormal cholesterol, and fatty liver disease can travel with insulin resistance and raise long-term cardiometabolic risk 1, 3. A good plan looks beyond glucose alone and addresses the full risk picture.

What medications are used when insulin resistance is part of a broader condition?

Medication may be used when insulin resistance is part of another condition, such as type 2 diabetes, prediabetes risk, PCOS, or obesity. There is no single FDA-approved medicine labeled only for insulin resistance, so the treatment target matters 1, 8.

Metformin is a biguanide drug class medication widely used for type 2 diabetes and sometimes discussed in prediabetes-risk or PCOS-related metabolic care. In women with PCOS, randomized research has compared metformin with myo-inositol as insulin-sensitizing approaches, which supports clinician-guided, PCOS-specific decision-making rather than blanket advice 8. You can read more in our guide to metformin for weight loss.

GLP-1 receptor agonists, such as Ozempic and Wegovy (semaglutide), and dual GIP/GLP-1 receptor agonists, such as Mounjaro and Zepbound (tirzepatide), may be relevant when a person meets weight-management or type 2 diabetes indications. FDA labels for semaglutide and tirzepatide describe uses tied to chronic weight management and/or glycemic control, along with risks such as gastrointestinal side effects and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 for these drug classes 11, 12, 13, 14.

Compounded semaglutide via a 503A pharmacy and compounded tirzepatide via a 503A pharmacy should not be described as the same as brand-name drugs. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data, so decisions should be based on a licensed clinician’s evaluation, the patient’s goals, safety history, and appropriate monitoring.

Insulin resistance treatment support at Chia: when weight-loss care may fit

Chia may fit when insulin resistance overlaps with a weight-management goal and a licensed provider finds GLP-1 care clinically appropriate. Our process is 100% online: a health questionnaire, licensed US provider review, provider-guided dosing, 503A pharmacy fulfillment, home delivery, and patient-portal messaging.

At Chia, semaglutide injection plans currently start at $249/mo, with provider-guided dosing and microdosing plans available. Semaglutide is a GLP-1 receptor agonist; we discuss it for eligible weight-management patients, not as a stand-alone cure for insulin resistance.

Chia also offers tirzepatide tablets or injection. Tirzepatide is a dual GIP/GLP-1 receptor agonist; plans currently start at $249/mo for tablets and $299/mo for injection, with provider-guided dosing and microdosing plans available.

Chia’s Weight + Energy and Weight + Muscle protocols use a choice of GLP-1 when clinically appropriate. Prescriptions are never guaranteed; eligibility depends on medical history, medications, contraindications, and provider judgment.

For patients using AI tools to organize care, DoctorMCP at mcp.chia.health can help route eligible prescription requests to Chia’s online evaluation. The clinical decision still rests with a licensed US provider.

When should you seek medical care for possible insulin resistance?

Medical care is the right next step if you have risk factors, abnormal labs, or symptoms of high blood sugar. Screening can catch prediabetes or type 2 diabetes before complications develop 1.

• Ask about screening if you have overweight or obesity, a large waist size, family history of type 2 diabetes, history of gestational diabetes, PCOS, sleep apnea, fatty liver disease, high blood pressure, abnormal cholesterol, or low physical activity 1.
• Seek prompt care for marked thirst, frequent urination, unexplained weight loss, vomiting, confusion, severe weakness, or rapidly worsening vision changes.
• Ask your clinician which tests make sense: A1C, fasting plasma glucose, oral glucose tolerance test, cholesterol panel, liver enzymes, blood pressure, and PCOS-related labs when relevant.
• If you already have abnormal blood sugar, ask how often to repeat labs and what changes would mean your plan needs adjustment.

FAQ about insulin resistance

Keep reading

Metabolic Health

Insulin Resistance and Diabetes: What’s the Connection?

Metabolic Health

Diabetes vs. Insulin Resistance: What’s the Difference?

Metabolic Health

Signs of Insulin Resistance: What to Notice and When to Get Tested